Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
36.24
USD
-1.07 (-2.87%)
Official Closing Price
Updated: 7:48 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Thinking about trading options or stock in Pfizer, Ligand Pharmaceuticals, Capital One Financial, GSX Techedu, or National Beverage?
Today 9:31 EST
InvestorsObserver issues critical PriceWatch Alerts for PFE, LGND, COF, GSX, and FIZZ.
From
PR Newswire
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments
Today 8:45 EST
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments
Today 8:45 EST
Financialnewsmedia.com News Commentary
From
PR Newswire
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)
Today 6:45 EST
Pfizer Inc. (NYSE: PFE) announced today co-primary endpoint results from a recently completed post-marketing required safety study, ORAL Surveillance (A3921133; NCT02092467). The primary objective of...
From
Business Wire News Releases
Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
January 26, 2021
From
GlobeNewswire News Releases
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
January 25, 2021
The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. Now, due to growing awareness...
From
PR Newswire
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
January 25, 2021
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
January 25, 2021
- BAVENCIO maintenance treatment significantly extended median overall survival versus standard of care in the Phase III JAVELIN Bladder 100 study
From
PR Newswire
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
January 22, 2021
Pfizer and BioNTech SE today announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021.
From
Business Wire News Releases
Thinking about trading options or stock in Intel Corp, Moderna, Microsoft, Pfizer, or Nvidia?
January 22, 2021
InvestorsObserver issues critical PriceWatch Alerts for INTC, MRNA, MSFT, PFE, and NVDA.
From
PR Newswire
ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
January 21, 2021
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug...
From
Business Wire News Releases
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
January 20, 2021
From
GlobeNewswire News Releases
Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?
January 15, 2021
InvestorsObserver issues critical PriceWatch Alerts for AAXN, TLRY, PFE, CRSP, and GM.
From
PR Newswire
Pfizer’s XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
January 14, 2021
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI® (crizotinib) for the treatment of pediatric...
From
Business Wire News Releases
Thinking about trading options or stock in Plug Power, Pfizer, Carnival Corp, American Airlines, or Bilibili?
January 12, 2021
InvestorsObserver issues critical PriceWatch Alerts for PLUG, PFE, CCL, AAL, and BILI.
From
PR Newswire
Researchers Seek to Better Understand Psychedelics' Role in New Therapies
January 12, 2021
FinancialBuzz.com News Commentary
From
PR Newswire
Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
January 12, 2021
Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative.
From
Business Wire News Releases
PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
January 12, 2021
PureTech Founded Entity Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative.
From
Business Wire News Releases
Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
January 12, 2021
Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth...
From
Business Wire News Releases
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
January 11, 2021
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
From
Business Wire News Releases
CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy
January 08, 2021
CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure for Duchenne muscular dystrophy (DMD), celebrates Pfizer Inc’s (NYSE: PFE) announcement surrounding the first dosing of...
From
Business Wire News Releases
Thinking about trading options or stock in Nio, Plug Power, Pfizer, Sorrento Therapeutics, or BioNTech?
January 08, 2021
InvestorsObserver issues critical PriceWatch Alerts for NIO, PLUG, PFE, SRNE, and BNTX.
From
PR Newswire
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
January 08, 2021
From
GlobeNewswire News Releases
Thinking about trading options or stock in Pfizer, Tesla, General Motors, JPMorgan Chase, or UnitedHealth Group?
January 07, 2021
InvestorsObserver issues critical PriceWatch Alerts for PFE, TSLA, GM, JPM, and UNH.
From
PR Newswire
Corinne Le Goff, Pharm.D. Will Join Moderna as Chief Commercial Officer on January 19
January 07, 2021
Corinne Le Goff, Pharm.D. will join Moderna as Chief Commercial Officer on January 19.
From
Business Wire News Releases
Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy
January 07, 2021
Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 CIFFREO study, which will evaluate the efficacy and safety of investigational gene therapy candidate...
From
Business Wire News Releases
ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology
January 07, 2021
ImaginAb Inc., a leading global provider of immuno-oncology imaging agents, today announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. (NYSE: PFE) to supply 89Zr CD8...
From
PR Newswire
Thinking about buying stock in Citigroup, Pfizer, CleanSpark, FuelCell Energy, or BP?
January 06, 2021
InvestorsObserver issues critical PriceWatch Alerts for C, PFE, CLSK, FCEL, and BP.
From
PR Newswire
Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
January 06, 2021
Dewpoint Therapeutics, the biomolecular condensates company, today announced a new research collaboration with Pfizer (NYSE: PFE) for the development of potential therapeutics for the treatment of...
From
PR Newswire
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference
January 05, 2021
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to two webcasts of discussions with Pfizer leadership at the 39th Annual J.P. Morgan Healthcare Conference to be held...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.